Cyclic Neutropenia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Cyclic Neutropenia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingEarly Phase 1

NCT07066085

Serial Blood Count Study

The objective of the Serial Blood Count Study is to determine the utility of home monitoring of white blood cell (WBC) and absolute neutrophil counts (ANC) to d…

United States20 participantsStarted 2024-10-17

Treatment: Serial Blood Count Study, Athelas Home device

All recent trials (15 shown)

CompletedNot Applicable

NCT05687474

Baby Detect : Genomic Newborn Screening

Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple…

Belgium6,824 participantsStarted 2022-09-01

CompletedNot Applicable

NCT02921191

Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated

Purpose: With the existing recombinant human granulocyte colony-stimulating factors (G-CSFs) patents expiring and the FDA approval of new biosimilar and innova…

Location not specified57,725 participantsStarted 2008-01

Treatment: filgrastim, TBO-filgrastim or pegfilgrastim

Cyclic Neutropenia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Serial Blood Count Study

All recent trials (15 shown)

Baby Detect : Genomic Newborn Screening

Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Serial Blood Count Study

All recent trials (15 shown)

Baby Detect : Genomic Newborn Screening

Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated

A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Can…

Various G-CSF Regimens to Prevent Infection During Chemotherapy

Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia

Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Profiling Neutrophil Counts in Patients on Chemotherapy

Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy